• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Pharmaceutical Market
Pharmaceutical News
Pharmaceutical Stocks
  • Pharmaceutical Market
  • Pharmaceutical News
  • Pharmaceutical Stocks
pharmaceutical investing

Will the Trump Administration Regenerate the Health Care Bill?

Written by Bryan Mc Govern
|
Apr. 04, 2017 02:53PM PST

After vowing to repeal Obamacare last month, Trump’s administration is now seeking a deal on a new health care bill.

On Monday (April 2), White House officials, including Vice President Mike Pence, offered a new version of the failed GOP health-care plan to appease far-right Republicans.
According to Bloomberg, House Speaker Paul Ryan said on Tuesday there isn’t a bill text or an agreement just yet. On the other hand Mark Walker, chairman of the conservative Republican Study Committee said it is being put together.
That said, an initial vote on the floor was set to take place on March 24 but, just before the voting went down, President Donald Trump asked speaker Paul Ryan to pull the bill.
“Obamacare’s the law of the land. It’s gonna remain the law of the land until it’s replaced. We did not have quite the votes to replace this law… we’re gonna be living with Obamacare for the foreseeable future,” said Ryan in a press conference following the defeat of his bill.


The new bill would allow states to apply for waivers for requirements on insurance companies under the affordable care act, according to the AP. One of those requirements prohibits insurance companies from declining to ensure people with serious diseases.
Before accepting the offer, Freedom Caucus members said they would prefer to see it in writing.
One of the key challenges the initial bill faced, besides complete dismissal from Democrats, was the lack of support from the Freedom Caucus, an ultra-right group that didn’t see the bill fully repealing Obamacare.
White House spokesperson Sean Spicer said the administration feels “very optimistic” about the discussions taking place regarding the bill and expects a resolution by the end of the week.
“Right now, we’re just at that conceptual stage about how to move forward in a way that can get everybody to 216,” Ryan told reporters today. The bill needs 216 votes in Congress so it may move on to the Senate.
“The administration is saying it would like it this week,” Bloomberg quoted Republican Representative Chris Collins of New York as saying. 
Following the failure of the original bill, president Trump tweeted the Freedom Caucus needed to “get on the team” otherwise they would hurt the entire Republican agenda, threatening to even challenge them in the Senate election next year.
On that note, the market reacted negatively to the failure of the original health-care bill. Despite the possibility for a GOP care plan to pass, the unpredictability of Trump’s presidency has proven to take a hit to the market, especially when he uses Twitter as a platform to attack groups or industries from tweets.
Don’t forget to follow us @INN_LifeScience for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
health care donald trump pharmaceutical investing affordable care act
The Conversation (0)

Go Deeper

AI Powered
Scientist pouring blue liquid from a test tube into a flask in a lab.

Biotech Market Forecast: Top Trends for Biotech in 2026

"America First" written on a chalkboard beside US flag.

The Mar-a-Lago Accord: What it is and What it Means for the Dollar, Global Trade and Gold

Latest News

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT

More News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Pharmaceutical Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES